These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 19555810

  • 1. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study.
    Levy RM, Saikovsky R, Shmidt E, Khokhlov A, Burnett BP.
    Nutr Res; 2009 May; 29(5):298-304. PubMed ID: 19555810
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis.
    Levy R, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R, Mazurov V, Bell M, Caldron P, Pillai L, Burnett B.
    Adv Ther; 2010 Dec; 27(12):953-62. PubMed ID: 20972845
    [Abstract] [Full Text] [Related]

  • 3. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee.
    Levy RM, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R, Mazurov V, Bell M, Caldron P, Pillai L, Burnett BP.
    Adv Ther; 2010 Oct; 27(10):731-42. PubMed ID: 20845002
    [Abstract] [Full Text] [Related]

  • 5. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.
    Pillai L, Burnett BP, Levy RM, GOAL Study Cooperative Group.
    Curr Med Res Opin; 2010 May; 26(5):1055-63. PubMed ID: 20225990
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
    Schiff M, Minic M.
    J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA.
    Am J Ther; 2011 Jul; 18(2):170-7. PubMed ID: 21317618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA.
    Walton SM, Schumock GT, McLain DA.
    Curr Med Res Opin; 2010 Sep; 26(9):2253-61. PubMed ID: 20690891
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P.
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J, Pivodic A, Aguirre D, Schnitzer TJ.
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S.
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [Abstract] [Full Text] [Related]

  • 16. A comparison of Naprelan and Naprosyn in the treatment of osteoarthritis of the knee.
    Schiff MH.
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):14-20. PubMed ID: 8886213
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial.
    Grube B, Grünwald J, Krug L, Staiger C.
    Phytomedicine; 2007 Jan; 14(1):2-10. PubMed ID: 17169543
    [Abstract] [Full Text] [Related]

  • 18. Using the medical food flavocoxid [corrected] in managing osteoarthritis.
    Gottlieb D, Kuritzky L.
    J Pain Palliat Care Pharmacother; 2011 Jan; 25(1):49-54. PubMed ID: 21426218
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial.
    Roth SH, Shainhouse JZ.
    Arch Intern Med; 2004 Oct 11; 164(18):2017-23. PubMed ID: 15477437
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis.
    Boussina I, Vischer TL.
    Pharmatherapeutica; 1987 Oct 11; 5(1):16-20. PubMed ID: 3602020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.